Brain Oxygen Optimization in Severe Traumatic Brain Injury Phase-II: A Phase II Randomized Trial*David O. Okonkwo, Ramon Diaz‐Arrastia, Lori Shutter et al.|Critical Care Medicine|2017Cited by 469
Disrupting the CD47-SIRPα anti-phagocytic axis by a humanized anti-CD47 antibody is an efficacious treatment for malignant pediatric brain tumorsSamuel Cheshier, Siddhartha S. Mitra, Abdullah H. Feroze et al.|Science Translational Medicine|2017Cited by 427
Prognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: a retrospective integrated clinical and molecular analysisEric M. Thompson, Tibor Hortobágyi, Gerald A. Grant et al.|The Lancet Oncology|2016Cited by 369
Six Degree-of-Freedom Measurements of Human Mild Traumatic Brain InjuryFidel Hernandez, David B. Camarillo, Lyndia C. Wu et al.|Annals of Biomedical Engineering|2014Cited by 213
Inter-site and inter-scanner diffusion MRI data harmonizationHengameh Mirzaalian, Yogesh Rathi, Lipeng Ning et al.|NeuroImage|2016Cited by 170